BRM:FRA
Bristol-Myers Squibb Co
51,53 €
0,00%
(0,00) 1D
14-окт., 15:47:09 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BRM...
Mkt. cap
121,09 млд
Avg. vol.
230,00
Volume
0,00
52-wk high
60,64 €
52-wk low
36,65 €
No. of employees
32 миң
Mkt. cap
121,09 млд
Avg. vol.
230,00
Volume
0,00
52-wk high
60,64 €
52-wk low
36,65 €
No. of employees
32 миң
News stories
From web sources and news partners
MarketWatch
·
9 саат мурун
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
ad-hoc-news.de
·
16 саат мурун
Wells Fargo cuts target for Bristol Myers Squibb stock to USD 60.00
BioSpace
·
19 саат мурун
J&J’s disappointing Q3, RevMed’s subgroup data, BMS’ ‘mixed’ results, Caribou’s cutback
The Motley Fool
·
1 күн мурун
Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees32,5 миң
Founded1887
HeadquartersНью-Йорк, Нью Йорк, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitebms.com